Through funding from the National Institute for Health and Care Research (NIHR), and in close collaboration with NIHR infrastructure and its counterparts in the devolved administrations, the ATTC network aims to build upon its existing work, expand its reach, and integrate its initiatives into standard practice.

The primary focus will be on rolling out clinical trial acceleration models across all UK ATMP delivery sites. By engaging with a wide range of stakeholders, iMATCH will then address the barriers to trial delivery by developing various tools that will transform, streamline and drive implementation of advanced therapy clinical trials within UK healthcare systems. These tools will include:

• ATMP-specific resources to support the NHS and industry to deliver ATMP clinical trials
• Master ATMP protocol guidance
• Standardised key trial documentation

By streamlining processes and implementing innovative methodologies, the iMATCH consortium aims to expedite the progression of ATMP clinical trials, ultimately bringing more innovative therapies to patients and strengthening the UK’s appeal to industry.